丁丙諾啡市場：依應用、給藥途徑、配銷通路及地區

2023年全球丁丙諾啡市場估計為55.2億美元，預計在預測期內（2023-2030年）複合年成長率為14.9%。

圖 1. 2023 年丁丙諾啡全球市場佔有率(%)，依應用分類

丁丙諾啡成為第一種在醫生診所開處方和分發的用於治療鴉片類藥物使用障礙的藥物，大大擴大了醫療保健的覆蓋範圍。與治療中使用的所有藥物一樣，丁丙諾啡應作為全面治療計劃的一部分開出，其中包括諮詢和其他服務，為患者提供整體治療方法。丁丙諾啡為鴉片類藥物使用疾患患者以及鴉片類藥物治療中心的治療感到不舒服或不合適的患者提供了許多好處。

以下丁丙諾啡產品已獲得美國FDA核准用於治療鴉片類藥物使用障礙。

• 非專利藥丁丙諾啡/納洛酮舌下片
• 丁丙諾啡舌下片（Subutex）
• 丁丙諾啡/納洛酮舌下膜（suboxone）
• 丁丙諾啡/納洛酮舌下片（Zubsolve）
• 丁丙諾啡/納洛酮口腔膜（Bunavale）
• 丁丙諾啡植入（普布啡）
• 丁丙諾啡緩釋注射液（Subrocade）

市場動態

增加對丁丙諾啡皮下使用的監管核准預計將在預測期內擴大全球丁丙諾啡市場。例如，2018年3月，製藥公司Indivior PLC宣布皮下注射用SUBLOCADE（丁丙諾啡緩釋）注射液（CIII）現已在美國上市。美國食品藥物管理局(FDA) 已批准使用 Sublocade 治療中度至重度鴉片類藥物使用障礙 (OUD) 的成年患者，這些患者已開始使用含丁丙諾啡的粘膜製劑治療，並已調整劑量至少7天，核准。丁丙諾啡只能由醫療專業人員給藥，並且應該成為綜合治療計劃的一部分，其中還包括諮商和社會心理支持。

本研究的主要特點

• 本報告對全球丁丙諾啡市場進行了詳細分析，並介紹了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
• 本報告還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
• 本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 本報告根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球丁丙諾啡市場的主要企業。
• 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
• 全球丁丙諾啡市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過用於分析全球丁丙諾啡市場的各種策略矩陣來促進決策。

目錄

第1章 研究目的與假設

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 市場機會
• 影響分析
• 主要亮點
• 產品發表會
• 技術進步
• PEST分析
• 監管場景
• 併購

第4章全球丁丙諾啡市場 - COVID-19 疾病的影響分析

• 經濟影響
• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 對需求和供給的影響

第5章全球丁丙諾啡市場，依應用分類，2018-2030

• 介紹
• 止痛藥
• 鴉片拮抗

第6章 全球丁丙諾啡市場，依給藥途徑，2018-2030

• 介紹
• 注射
• 舌下
• 經皮的

第 7 章全球丁丙諾啡市場，依配銷通路分類，2018-2030

• 介紹
• 醫院藥房
• 零售藥房
• 線上藥房

第8章全球丁丙諾啡市場，依地區，2018-2030

• 介紹
• 北美洲
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 東南亞國協
• 澳洲
• 韓國
• 其他亞太地區
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中部非洲
• 南非

第9章競爭形勢

• Mallinckrodt
• Noramco
• Unichem Laboratories Ltd.
• Sanofi
• Johnson Matthey
• Arevipharma Gmbh
• Resonance Laboratories Pvt. Ltd.
• Sun Pharmaceutical Industries Limited
• Rusan Pharma Ltd.
• Micro Orgo Chem
• Faran Shimi Pharmaceutical
• Indivior PLC
• Titan Pharmaceuticals, Inc.
• Hikma Pharmaceuticals PLC.

第10章

• 調查方法
• 關於出版商

The global buprenorphine market is estimated to be valued at US$ 5.52 Billion in 2023 and is expected to exhibit a CAGR of 14.9% during the forecast period (2023-2030).

Figure 1. Global Buprenorphine Market Share (%), by Application, 2023

Buprenorphine is the first medication to treat opioid use disorder that may be prescribed or distributed in doctor's offices, vastly expanding access to care. Buprenorphine should be prescribed as a component of a thorough treatment plan that includes counseling and other services to give patients a whole-person approach, as is the case with all drugs used in therapy. Buprenorphine provides a number of benefits for those with opioid use disorder and for those for whom therapy at an opioid treatment center is uncomfortable or inappropriate.

The following buprenorphine products are approved for the treatment of opioid use disorder by the U.S. FDA:

• Generic buprenorphine/naloxone sublingual tablets
• Buprenorphine sublingual tablets (Subutex)
• Buprenorphine/naloxone sublingual films (Suboxone)
• Buprenorphine/naloxone sublingual tablets (Zubsolv)
• Buprenorphine/naloxone buccal film (Bunavail)
• Buprenorphine implants (Probuphine)
• Buprenorphine extended-release injection (Sublocade)

Market Dynamics

Increasing approval of buprenorphine by regulatory authorities for subcutaneous use is expected to increase the global buprenorphine market over the forecast period. For instance, in March, 2018, Indivior PLC, a pharmaceutical company, announced that SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use (CIII), is available in the U.S. The U.S. Food and Drug Administration (FDA) has granted approval for the use of SUBLOCADE for the treatment of moderate to severe opioid use disorder (OUD) in adult patients who have started therapy with a transmucosal buprenorphine-containing medication and have undergone dose titration for at least seven days. It should only be given by medical professionals, and it should be part of a comprehensive treatment plan that also includes counseling and psychosocial support.

Key features of the study:

• This report provides in-depth analysis of the global buprenorphine market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global buprenorphine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Mallinckrodt, Noramco, Unichem Laboratories Ltd., Sanofi, Johnson Matthey, Arevipharma Gmbh, Resonance Laboratories Pvt. Ltd., Sun Pharmaceutical Industries Limited, Rusan Pharma Ltd. Micro Orgo Chem, Faran Shimi Pharmaceutical, Indivior PLC, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global buprenorphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global buprenorphine market

Detailed Segmentation:

• By Application:
  • Analgesic
  • Opioid Antagonist
• By Route of Administration:
  • Injectables
  • Sublingual
  • Transdermal
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Mallinckrodt
  • Noramco
  • Unichem Laboratories Ltd.
  • Sanofi
  • Johnson Matthey
  • Arevipharma Gmbh
  • Resonance Laboratories Pvt. Ltd.
  • Sun Pharmaceutical Industries Limited
  • Rusan Pharma Ltd.
  • Micro Orgo Chem
  • Faran Shimi Pharmaceutical
  • Indivior PLC
  • Titan Pharmaceuticals, Inc.
  • Hikma Pharmaceuticals PLC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product Launch
• Technological Advancements
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global Buprenorphine Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Buprenorphine Market, By Application, 2018-2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Analgesic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Opioid Antagonist
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Buprenorphine Market, By Route of Administration, 2018-2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Injectables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Sublingual
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Transdermal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Buprenorphine Market, By Distribution Channel, 2018-2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segments Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Buprenorphine Market, By Region, 2018-2030, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Mallinckrodt
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Noramco
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Unichem Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson Matthey
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Arevipharma Gmbh
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Resonance Laboratories Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sun Pharmaceutical Industries Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Rusan Pharma Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Micro Orgo Chem
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Faran Shimi Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Indivior PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Titan Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Hikma Pharmaceuticals PLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us